Opening Recap Market Pulse: Markets drifted on mixed signals from heavy cash burn headlines and...
Archive - February 3, 2026
PCVX: Major $632.5M Offering Boosts Growth Potential!
Introduction Vaxcyte, Inc. (NASDAQ: PCVX) is a clinical-stage vaccine developer that has recently...